Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children
NCT ID: NCT05237232
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2022-03-31
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to model cerebral flow in children who have been cared from jugulocarotid ECMO and compare cerebral hemodynamics according to the technique of reconstruction of the common carotid artery after decanulation (reconstruction or ligation).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Estimation of Central Venous Pressure by Echocardiography in Intubated Children in Pediatric Intensive Care
NCT05195424
Brain Ultrasound in the Weaning of External Ventricular Leads
NCT03531723
Research on Prevention, Early Detection, and Clinical Evaluation of Intracranial Hemorrhage in Preterm Infants
NCT07157020
Non Invasive Measurement With Trans Cranial Doppler Versus Invasive Measurement in Pediatric Age
NCT05340062
Traumatic Extradural Hematoma in Paediatric Age Group
NCT05552703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When ECMO is stopped, carotid decanulation is done either by ligation or by reconstruction, depending on the practices of the surgical team and the peroperative findings. The reconstruction allows a restoration of blood flow to the internal carotid artery and the middle cerebral artery with a disappearance of compensation by the circle of Willis.
Vascular flow modeling is a computational method derived from imaging for the hemodynamic study of fluids, including pressures and flow rates at different points in a vessel. Data from the literature on the modeling of cerebral vascularization in newborns are scarce.
This study aims to model cerebral flow in children who have been cared from jugulocarotid ECMO and compare cerebral hemodynamics according to the technique of reconstruction of the common carotid artery after decanulation (reconstruction or ligation).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Newborns, infants and children hospitalized in pediatric intensive care unit (PICU) at Trousseau Hospital, having been treated with jugulocarotid ECMO and weaned alive off ECMO.
Modeling cerebral vascularization
The modeling of cerebral vascularization from CRIMSON software (CaRdiovascular Integrated Modeling \& Simulation) requires several inputs:
* The MRA images
* The cardiac function curve
* The cerebral blood flow
* Measurement of systolic, diastolic and mean arterial blood pressure
Controls
Newborns treated for hypoxic-ischemic encephalopathy in the PICU of Trousseau Hospital.
Magnetic Resonance Angiography (MRA) additional acquisition time
Additional acquisition time, time of flight, during brain MRA of the care allowing to obtain the same quality of vascular anatomical visualization as the brain MRA with gadolinium contrast medium injection performed for the care of the patients treated with jugulocarotid ECMO.
Modeling cerebral vascularization
The modeling of cerebral vascularization from CRIMSON software (CaRdiovascular Integrated Modeling \& Simulation) requires several inputs:
* The MRA images
* The cardiac function curve
* The cerebral blood flow
* Measurement of systolic, diastolic and mean arterial blood pressure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic Resonance Angiography (MRA) additional acquisition time
Additional acquisition time, time of flight, during brain MRA of the care allowing to obtain the same quality of vascular anatomical visualization as the brain MRA with gadolinium contrast medium injection performed for the care of the patients treated with jugulocarotid ECMO.
Modeling cerebral vascularization
The modeling of cerebral vascularization from CRIMSON software (CaRdiovascular Integrated Modeling \& Simulation) requires several inputs:
* The MRA images
* The cardiac function curve
* The cerebral blood flow
* Measurement of systolic, diastolic and mean arterial blood pressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Information and non-opposition of holders of parental authority
2. Newborn, infant and child \<20kg
3. Hospitalization in pediatric and neonatal intensive care unit (PICU) of Trousseau Hospital
4. Performing a Magnetic Resonance Angiography (MRA) as part of the treatment
For patients treated with ECMO: study population
5. Hemodynamic or respiratory failure
6. Requiring the use of extracorporeal circulation with jugulo-carotid cannulation
7. Weaned alive off Extra corporeal membrane oxygenation (ECMO)
For patients with hypoxic-ischemic encephalopathy: control population
8. hypoxic-ischemic encephalopathy diagnosed at birth
Exclusion Criteria
2. Opposition of holders of parental authority
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sabine Irtan, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Garance Martin, MD
Role: STUDY_DIRECTOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Trousseau
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01935-36
Identifier Type: OTHER
Identifier Source: secondary_id
APHP211306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.